The article Field Trip Announces New Ketamine Therapy Program: Freedom by Field Trip™ was originally published on Microdose. Field Trip Announces the...
The psychedelics research company ended the quarter with less than $100K cash. The post Mydecine Continues Cash Burn through Q3 appeared first on Green...
There is a high rate of adverse physical effects and challenging psychological effects from using the plant-based psychoactive ayahuasca, though they are...
You may have never heard of psilacetin. In fact, when you first saw it, it may have confused you. “Is this a misspelling of psilocybin? Is...
ReMind Psychedelics Business Forum was held Nov. 15 in Las Vegas. The post A Psychedelics Forum: How the Industry is Evolving into Tomorrow appeared first...
The article Elon Talks Psychedelics: Is he Helping or Hurting the Movement? was originally published on Microdose. “Amphetamines negatively affect empathy,...
The self-dubbed “world’s leading psychedelic event" brought together a menagerie of industry titans, entrepreneurs, and psychedelic luminaries, showcasing...
Too few medical schools offer training in the use of psychedelics therapy. The post Combatting the Medical Training Gap Around Psychedelics appeared first...
In this edition of Mindshifting Moments, Margaret Williamson is joined by Todd Shapiro and Sarah Hashkes of Red Light Holland. The conversation answers...
If you are reading this, you probably turn to a doctor with a reputable medical degree when you get sick. Most people, however, do not have...
The article Alberta’s Psychedelic Therapy Laws: What Are the Implications? was originally published on Microdose. In diverse cities, provinces and states...
Beckley Psytech, a private, clinical-stage biotechnology company dedicated to addressing neuropsychiatric conditions through the novel application of psychedelic...
Cybin Inc. (NEO:CYBN | NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics®, today announced that the...
The article Clearmind Medicine Uplists to the NASDAQ was originally published on Microdose. In surprising news, lesser-known psychedelic upstart Clearmind...
Cybin Inc. (NEO:CYBN) (NYSE American:CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics®, today reported unaudited...